TRI-611 shows potential as brain-penetrant degrader for ALK-positive lung cancer

Preclinical data indicate the molecular glue degrades ALK fusion proteins via a novel CRBN motif, offering a new treatment avenue.

1 publisher · 1 article · first seen 9 Sept 2026 · updated 4d ago

This story has stopped developing; this page is its permanent record. More from that day